 |
|
|
Home > USA > Meet Italy at Bio 2007
SARDEGNA RICERCHE - THE SCIENCE & TECHNOLOGY PARK OF SARDINIA
Edificio 2, Località Piscinamanna - 09010 Pula (CA), ITALY
Telephone: 0039 070 92432204
Fax: 0039 070 92432203
E-mail: songini@sardegnaricerche.it
Web site: www.sardegnaricerche.it
Contact: Mr. Valter Songini
At a Glance
Status: Science park
Date of foundation: 2003
Main Activity
The Science &Technology Park of Sardinia, was promoted by SARDEGNA RICERCHE, a Public Agency appointed by the Sardinia Regional Government to create and manage it. The park has two centres, with different areas of scientific- technological specialization:
- The Head-Office is set in Pula, in the Sulcis Nature Park on a 160 hectares green area property, with a 25,000 mq built area, just 30 minutes from Cagliari and its international airport.
- The local branch is set in Alghero-Tramariglio, in the north-western coast of Sardinia, on 3,5 hectares green area property, with a 10,000 mq built area. It is managed by Porto Conte Ricerche company. Today, the park hosts 50 research institutes and companies, and more than 400 people working in the field of Information and Communication Technologies, Biomedicine, Bioinformatics (in Pula) and Proteomics, Nanotechnologies, Agroindustrial Technologies, Biodiversity, Environment (in Alghero).
The following technological platforms are available at the park: Bioinformatics, Genotyping and Gene expression profiling, Pharmacology, Medical Devices, Proteomic Biotechnologies, NMR Spectrometry and Analytical Chemistry.
Company Strengths
R&D CAPACITY:
Sardinia plays a leading role in the biotech sector, that shows broad expansion potential.
According to a recent report by Blossom-Assobiotec, Sardinia is sixth among Italian regions for number of biotech companies and first among those of Southern Italy. This thanks to different factors:
- genetic drift phenomena (the so-called genetic isolates), the result of thousands of years of geographical isolation, which makes Sardinia the ideal place for the identification of the genetic causes of complex diseases and the risk factors associated with them;
- the presence of highly qualified local researchers and technicians in ICT and Life Sciences, strongly oriented to interaction, two local universities, National Research Council Institutes, several public and private research centres;
- "state of the art":infrastructures such as the Science & Technology Park
- The investments by local authorities for R&D activities.
These policies have concretely produced a Biomedicine and Health Technology District, one of the only two Italian Technology Districts officially recognized by the Ministry of University and Research, and the creation of a pole of excellence for bioinformatic technologies for personalized medicine.
The Sardinia local government has recently set up a new public company, called "Phase One" (Fase Uno). The aim of "Phase One" is to contribute to the development of a local strategy and successively national strategy for preclinical evaluation and patent evaluation of new substances biologically active to be brought in clinic Phase I and II. The activities will focus on the development of new drugs, new therapeutic applications, technology transfer of know how and procedures and finally assistance for the development, registration, production and commercialization of therapeutic and diagnostic products.
The new company will also be able to provide the necessary support to pharmaceutical companies to develop and test, in Sardinia, their own products up to the clinical phase necessary for the registration of a new drug.
Sector
BIOTECHNOLOGY
MEDICAL BIOTECHNOLOGY
- biomedicine
-bioinformatics
-drug delivery and medical devices
-genome pharmacology
- research and development
Type of Cooperation
GENERAL CO-OPERATION
-DEVELOPMENT OF NEW PROJECTS
- DEVELOPMENT OF NEW COMPANIES TO BE LOCATED IN THE PARK
|
|
